Commonwealth Equity Services, LLC Bio N Tech Se Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 3,138 shares of BNTX stock, worth $338,527. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,138

Previous 3,159 0.66%

Holding current value

$338,527

Previous $254,000 46.85%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$78.36 - $124.66 $1,645 - $2,617	-21 Reduced 0.66%	3,138 $373,000
Q2 2024 Jul 31, 2024	SELL	$80.36 - $102.87 $54,403 - $69,642	-677 Reduced 17.65%	3,159 $254,000
Q1 2024 Apr 29, 2024	SELL	$88.96 - $112.35 $626,545 - $791,281	-7,043 Reduced 64.74%	3,836 $354,000
Q4 2023 Feb 06, 2024	BUY	$90.91 - $112.75 $23,636 - $29,315	260 Added 2.45%	10,879 $1.15 Million
Q3 2023 Oct 23, 2023	SELL	$98.5 - $125.08 $75,451 - $95,811	-766 Reduced 6.73%	10,619 $1.15 Million
Q2 2023 Aug 10, 2023	SELL	$102.58 - $129.66 $26,157 - $33,063	-255 Reduced 2.19%	11,385 $1.23 Million
Q1 2023 May 11, 2023	BUY	$122.57 - $153.67 $392,591 - $492,205	3,203 Added 37.96%	11,640 $1.45 Million
Q4 2022 Feb 07, 2023	SELL	$118.43 - $186.05 $570,358 - $896,016	-4,816 Reduced 36.34%	8,437 $1.27 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $1.11 Million - $1.59 Million	8,684 Added 190.06%	13,253 $1.79 Million
Q2 2022 Jul 19, 2022	SELL	$123.25 - $186.24 $57,804 - $87,346	-469 Reduced 9.31%	4,569 $681,000
Q1 2022 May 04, 2022	SELL	$126.25 - $231.85 $234,446 - $430,545	-1,857 Reduced 26.93%	5,038 $859,000
Q4 2021 Jan 31, 2022	SELL	$216.64 - $362.52 $218,373 - $365,420	-1,008 Reduced 12.75%	6,895 $1.78 Million
Q3 2021 Oct 29, 2021	SELL	$205.93 - $447.23 $28,624 - $62,164	-139 Reduced 1.73%	7,903 $2.16 Million
Q2 2021 Aug 11, 2021	SELL	$113.32 - $241.49 $59,832 - $127,506	-528 Reduced 6.16%	8,042 $1.8 Million
Q1 2021 May 04, 2021	BUY	$85.73 - $119.5 $65,926 - $91,895	769 Added 9.86%	8,570 $935,000
Q4 2020 Feb 11, 2021	BUY	$72.71 - $129.54 $162,724 - $289,910	2,238 Added 40.23%	7,801 $635,000
Q3 2020 Nov 05, 2020	BUY	$57.81 - $104.17 $321,597 - $579,497	5,563 New	5,563 $385,000

Others Institutions Holding BNTX

# of Institutions

323

Shares Held

38.9M

Call Options Held

845K

Put Options Held

1.28M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Bio N Tech Se Transaction History